About NorthGene
NorthGene is a company based in Newcastle Upon Tyne (United Kingdom) founded in 1994 was acquired by QuantuMDx in November 2012. It operates as a HealthTech and Direct-to-Consumer (D2C). The company has 32 employees as of March 31, 2022. NorthGene offers products and services including Paternity Testing, STI Testing, and Siblingship Testing. NorthGene operates in a competitive market with competitors including DDC Paternity Tests, IntegenX, Othram, ANDE and Applied DNA Sciences, among others.
- Headquarter Newcastle Upon Tyne, United Kingdom
- Employees 32 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biofortuna Limited
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NorthGene
NorthGene offers a comprehensive portfolio of products and services, including Paternity Testing, STI Testing, and Siblingship Testing.
Biological father determination through DNA sample analysis.
Testing for sexually transmitted infections like Chlamydia.
Determining full or half sibling relationships genetically.
Funding Insights of NorthGene
Detailed funding history for NorthGene
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in NorthGene
NorthGene has secured backing from 1 investor. Prominent investors backing the company include QuantuMDx.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
Locked | Locked | Locked |
Investor details for NorthGene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NorthGene
Investment portfolio details for NorthGene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NorthGene
Detailed financials for NorthGene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Northgene Comparisons
Peer comparison for NorthGene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NorthGene
NorthGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DDC Paternity Tests, IntegenX, Othram, ANDE and Applied DNA Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA tests and personalized diagnostics are provided for various specialties.
|
|
| Locked | Locked | Locked |
Instruments for rapid human DNA identification are developed.
|
|
| Locked | Locked | Locked |
Genomic services are provided for forensic investigations and research.
|
|
| Locked | Locked | Locked |
Rapid DNA systems are provided for forensic identification and diagnostics.
|
|
| Locked | Locked | Locked |
Botanical-DNA-based security and authentication solutions are developed.
|
|
| Locked | Locked | Locked |
Integrated genomics solutions are offered for forensics and infectious diseases.
|
Detailed competitors of NorthGene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Northgene
Complete news archive for NorthGene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NorthGene
NorthGene was founded in 1994.
NorthGene is headquartered in Newcastle Upon Tyne, United Kingdom.
As of Mar 31, 2022, the latest employee count at NorthGene is 32.
NorthGene, a trading name of Biofortuna Limited, is involved in offering a range of DNA relationship testing services such as paternity, maternity, siblingship, and grandparentage testing for peace of mind, legal, and immigration purposes. Additionally, health testing for sexually transmitted infections like Chlamydia and Gonorrhoea is provided. Operating from accredited UK-based laboratories, services are extended to the public, legal professionals, coroners, and embassies. The focus is on delivering fast, accurate, and confidential results across personal and forensic sectors.
NorthGene's top competitors include DDC Paternity Tests, Key Forensic Services and Applied DNA Sciences.
NorthGene offers Paternity Testing, STI Testing, and Siblingship Testing.
NorthGene has 1 investor. Key investors include QuantuMDx.